Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$84.35

0.33 (0.39%)

, NVO

Novo Nordisk

$42.98

0.37 (0.87%)

06:22
07/17/17
07/17
06:22
07/17/17
06:22

Eli Lilly's launch in type 2 diabetes 'remarkable,' says Piper Jaffray

Piper Jaffray analyst Richard Purkiss is highlighting the "remarkable growth story" of Eli Lilly's (LLY) once-weekly GLP-1 agonist Trulicity for type 2 diabetes. At its current pace, Trulicity would become market leader in the GLP-1 space in the early part of next year, surpassing Novo Nordisk's (NVO) Victoza, Purkiss tells investors in a research note. He views Lilly's launch as "quite simply unique in the current climate." Lilly remains one of the analyst's top 2017 picks with an Overweight rating and $102 price target.

LLY

Eli Lilly

$84.35

0.33 (0.39%)

NVO

Novo Nordisk

$42.98

0.37 (0.87%)

  • 17

    Jul

  • 19

    Jul

  • 25

    Jul

  • 11

    Sep

LLY Eli Lilly
$84.35

0.33 (0.39%)

06/27/17
06/27/17
NO CHANGE

Large cap pharma could benefit from upcoming executive order, says Wells Fargo
Wells Fargo says that, based on press reports, large cap pharma could benefit from President Trump's upcoming executive order on drug pricing. The firm says the articles indicate that the order will not create major reforms or do anything to lower consumers' costs or solve current pricing issues. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Eli Lilly has positive read through from J&J data, says SunTrust
SunTrust analyst John Boris says that data for Johnson & Johnson's (JNJ) Invokana for diabetes represented a best-case scenario for Eli Lilly (LLY). J&J's drug "significantly reduced the combined risk of cardiovascular death, myocardial infarction and nonfatal stroke in diabetes patients at risk for or with a history of CV diseases," and its efficacy on CV death is positive for the SGLT-2 class, to which Eli Lilly's Jardiance also belongs, according to the analyst. But the data leaves Jardiance, which reduced CV death by a statistically significant 38% versus Invokana's non-significant 13%, as the best in the class, wrote the analyst, who reiterates a $101 price target and a Buy rating on Eli Lilly.
06/12/17
LEER
06/12/17
NO CHANGE
Target $90
LEER
Outperform
Eli Lilly price target lowered to $90 from $93 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Eli Lilly (LLY) to $90 to reflect reduced sales forecasts for baricitinib, an oral JAK1/2 inhibitor to treat rheumatoid arthritis which the company collaborates with Incyte (INCY). Following AbbVie's (ABBV) positive Phase 3 data last week for its JAK1 inhibitor upadacitinib, Fernandez dropped his U.S. peak sales estimate for baricitinib by more than 50% to $400M and pushed out his U.S. launch time to 2020 from 2018. The analyst keeps an Outperform rating on Lilly shares.
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
NVO Novo Nordisk
$42.98

0.37 (0.87%)

04/07/17
04/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lamb Weston (LW) downgraded to Hold from Buy at Stifel with analyst Christopher Growe citing the 44% up move in shares since he launched coverage in November 2016. 2. AstraZeneca (AZN), Novo Nordisk (NVO), Sanofi (SNY), Roche (RHHBY), and Grifols (GRFS) were downgraded to Reduce from Hold at HSBC. 3. AECOM (ACM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying the company filed an amendment to its credit agreement suggesting likely risk to 2017 earnings, as the filing implies the company would have breached its leverage covenant without an amendment. The analyst is also cautious given the relative obscurity of the filing. Wittmann lowered his price target to $40 from $45 on AECOM shares. 4. Arista Networks (ANET) downgraded to Neutral on valuation at Nomura with analyst Jeffrey Kvaal citing valuation. 5. Maximus (MMS) downgraded to Hold from Buy at Canaccord analyst Richard Close citing expectations of a slow near-term RFP and contract award environment given the recent Trump administration transition. click here.
04/07/17
HSBC
04/07/17
DOWNGRADE
HSBC
Reduce
Novo Nordisk downgraded to Reduce from Hold at HSBC
HSBC analyst Steve McGarry downgraded Novo Nordisk to Reduce to reflect lackluster news flow, valuation risk, and a sector backdrop where US pricing pressure could intensify.
03/21/17
WEDB
03/21/17
INITIATION
WEDB
Outperform
Global Blood Therapeutics coverage assumed with an Outperform at Wedbush
Wedbush analyst Liana Moussatos says that Global Blood Therapeutics' (GBT) GBT440 drug can become the standard of care for sickle cell disease, and he thinks that the stock has not risen adequately following speculation that the company had been approached by Novo Nordisk(NVO) about a takeover. The analyst thinks that the company could be acquired for $73-$87 per share, versus its current price of around $37. Target $73.
03/07/17
LEHM
03/07/17
NO CHANGE
LEHM
European Pharma raised to Positive from Neutral at Barclays
Barclays analyst Emmanuel Papadakis rolled out coverage of the European Pharmaceuticals space and upgraded his sector view to Positive from Neutral. The analyst has "high conviction that the recent transformational era of R&D innovation is set to continue," which he believes will allow the sector to retain pricing power. Papadakis put Overweight ratings on AstraZeneca (AZN), Roche (RHHBY) and Shire (SHPG), with Astra his top pick. The analyst put an Equal Weight rating on GlaxoSmithKline (GSK) and Underweight ratings on Sanofi (SNY), Novartis (NVS) and Novo Nordisk (NVO).

TODAY'S FREE FLY STORIES

03:25
07/25/17
07/25
03:25
07/25/17
03:25
General news
FX Action: USD-JPY dipped back to around the 111.00 level »

FX Action: USD-JPY dipped…

02:40
07/25/17
07/25
02:40
07/25/17
02:40
General news
FX Update: Narrow ranges have been the order of the day »

FX Update: Narrow ranges…

MMM

3M

$210.00

-1.16 (-0.55%)

, MCD

McDonald's

$151.85

-2.07 (-1.34%)

20:25
07/24/17
07/24
20:25
07/24/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MMM

3M

$210.00

-1.16 (-0.55%)

MCD

McDonald's

$151.85

-2.07 (-1.34%)

UTX

United Technologies

$123.13

-0.36 (-0.29%)

LLY

Eli Lilly

$84.74

0.08 (0.09%)

DD

DuPont

$84.35

-0.19 (-0.22%)

CAT

Caterpillar

$108.18

1.59 (1.49%)

BIIB

Biogen

$284.70

1.78 (0.63%)

GM

General Motors

$35.82

-0.25 (-0.69%)

KMB

Kimberly-Clark

$123.81

-1.47 (-1.17%)

HCA

HCA Holdings

$86.09

0.36 (0.42%)

PCAR

Paccar

$69.14

0.27 (0.39%)

TROW

T. Rowe Price

$81.10

0.27 (0.33%)

FCX

Freeport McMoRan

$12.96

-0.05 (-0.38%)

NEM

Newmont Mining

$33.90

-0.49 (-1.42%)

DGX

Quest Diagnostics

$109.44

0.05 (0.05%)

WAT

Waters

$185.01

-0.23 (-0.12%)

CNC

Centene

$84.20

-0.53 (-0.63%)

STX

Seagate

$39.76

0.18 (0.45%)

DPZ

Domino's Pizza

$213.97

0.75 (0.35%)

IPG

Interpublic Group

$25.57

0.06 (0.24%)

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

LW

Lamb Weston

$44.75

-0.25 (-0.56%)

GPK

Graphic Packaging

$13.77

0.04 (0.29%)

AKS

AK Steel

$6.03

-0.17 (-2.74%)

SVU

Supervalu

$3.25

-0.01 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 10

    Aug

  • 15

    Aug

  • 23

    Aug

  • 11

    Sep

  • 11

    Sep

  • 15

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

QCOM

Qualcomm

$53.22

-0.62 (-1.15%)

, AAPL

Apple

$152.09

1.82 (1.21%)

19:16
07/24/17
07/24
19:16
07/24/17
19:16
Periodicals
Qualcomm claims tech group misdirects trade regulators, Reuters says »

Qualcomm (QCOM) has…

QCOM

Qualcomm

$53.22

-0.62 (-1.15%)

AAPL

Apple

$152.09

1.82 (1.21%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

MSFT

Microsoft

$73.60

-0.19 (-0.26%)

FB

Facebook

$166.00

1.57 (0.95%)

INTC

Intel

$34.50

-0.23 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 10

    Aug

  • 15

    Aug

  • 05

    Sep

  • 13

    Sep

SMBC

Southern Missouri Bancorp

$31.32

-0.38 (-1.20%)

18:53
07/24/17
07/24
18:53
07/24/17
18:53
Hot Stocks
Southern Missouri Bancorp increases dividend 10% to 11c »

Missouri Bancorp …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

18:47
07/24/17
07/24
18:47
07/24/17
18:47
Periodicals
VW diesel car owners declining refit to lose registration, Reuters says »

Owners of Volkswagen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRCI

SRC Energy

$7.17

0.04 (0.56%)

18:43
07/24/17
07/24
18:43
07/24/17
18:43
Hot Stocks
SRC Energy says 36 gross wells seen adding to production in 2H »

SRC continues to execute…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Aug

BABA

Alibaba

$152.26

0.37 (0.24%)

18:42
07/24/17
07/24
18:42
07/24/17
18:42
Periodicals
Alibaba in talks to make major investment in Tokopedia, Bloomberg says »

Alibaba is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$109.41

0.1 (0.09%)

18:39
07/24/17
07/24
18:39
07/24/17
18:39
Periodicals
Toyota could sell new generation of EVs in Japan in 2022, Bloomberg says »

Toyota may sell the next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$20.25

-0.25 (-1.22%)

18:27
07/24/17
07/24
18:27
07/24/17
18:27
Periodicals
Carlyle seeks $15B for new U.S. buyout fund, Bloomberg reports »

Carlyle Group is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

, TCEHY

Tencent

$38.98

0.785 (2.06%)

18:24
07/24/17
07/24
18:24
07/24/17
18:24
Periodicals
Daimler invests in Chinese self-driving startup Momenta, WSJ reports »

Daimler (DDAIF) is…

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

TCEHY

Tencent

$38.98

0.785 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRBA

First Bank

$12.30

0.05 (0.41%)

18:22
07/24/17
07/24
18:22
07/24/17
18:22
Earnings
First Bank reports Q2 EPS 15c, consensus 17c »

Reports Q2 revenue $9.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PCH

Potlatch

$47.55

-0.55 (-1.14%)

18:22
07/24/17
07/24
18:22
07/24/17
18:22
Earnings
Potlatch reports Q2 EPS 59c, consensus 35c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CAT

Caterpillar

$108.18

1.59 (1.49%)

18:17
07/24/17
07/24
18:17
07/24/17
18:17
Periodicals
Caterpillar poised to move higher, Barron's reports »

At approximately 20 times…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HA

Hawaiian Holdings

$44.80

-0.5 (-1.10%)

, EADSY

Airbus

$20.89

-0.005 (-0.02%)

18:16
07/24/17
07/24
18:16
07/24/17
18:16
Hot Stocks
Hawaiian unveils three new west coast routes, begins sales for A321neo flights »

Hawaiian Airlines (HA)…

HA

Hawaiian Holdings

$44.80

-0.5 (-1.10%)

EADSY

Airbus

$20.89

-0.005 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GS

Goldman Sachs

$218.18

-2 (-0.91%)

17:53
07/24/17
07/24
17:53
07/24/17
17:53
Periodicals
Goldman Sachs pulls back from ETF lead market making, Reuters reports »

Goldman Sachs is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 01

    Aug

  • 17

    Oct

IBM

IBM

$145.99

-1.09 (-0.74%)

17:48
07/24/17
07/24
17:48
07/24/17
17:48
Hot Stocks
IBM granted patent to protect cryptographic keys and codes »

IBM announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$980.34

7.42 (0.76%)

17:48
07/24/17
07/24
17:48
07/24/17
17:48
Hot Stocks
Breaking Hot Stocks news story on Alphabet »

Alphabet's Pichai…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CWH

Camping World

$31.15

-0.7 (-2.20%)

17:46
07/24/17
07/24
17:46
07/24/17
17:46
Hot Stocks
Camping World acquires American RV in Gran Rapids, Michigan »

Camping World Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$980.34

7.42 (0.76%)

17:39
07/24/17
07/24
17:39
07/24/17
17:39
Hot Stocks
Breaking Hot Stocks news story on Alphabet »

Alphabet CEO says not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

GOOG

Alphabet

$980.34

7.42 (0.76%)

17:37
07/24/17
07/24
17:37
07/24/17
17:37
Hot Stocks
Breaking Hot Stocks news story on Alphabet »

Alphabet says seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

DKL

Delek Logistics

$34.70

-0.3 (-0.86%)

17:33
07/24/17
07/24
17:33
07/24/17
17:33
Hot Stocks
Delek Logistics increases dividend 2.2c to 70.5c »

Delek Logistics Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AIRT

Air T

$16.00

0.05 (0.31%)

17:32
07/24/17
07/24
17:32
07/24/17
17:32
Hot Stocks
Air T receives Nasdaq notice letter »

Air T announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFSC

Enterprise Financial

$40.70

0.45 (1.12%)

17:31
07/24/17
07/24
17:31
07/24/17
17:31
Earnings
Enterprise Financial reports Q2 core EPS 56c, consensus 62c »

Rreports Q2 return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

CLB

Core Laboratories

$106.30

0.61 (0.58%)

17:30
07/24/17
07/24
17:30
07/24/17
17:30
Hot Stocks
Breaking Hot Stocks news story on Core Laboratories »

Core Laboratories reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.